Valuation EUROAPI London S.E.

Stocks

Real-time Estimate Tradegate Other stock markets 03:33:35 30/07/2026 pm IST			5-day change	1st Jan Change
0.9600 ^EUR	-24.11%		-3.98%	-47.81%

01:20pm	Euroapi S.A., Q2 2026 Earnings Call, Jul 30, 2026
30/07	Euroapi S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,302	543.9	274.4	216.1	120.1	-	-
Change	-	-58.23%	-49.55%	-21.22%	-44.42%	-	-
Enterprise Value (EV) ¹	1,348	734.9	270.5	167.7	78.47	115.1	122
Change	-	-45.5%	-63.2%	-37.98%	-53.22%	46.64%	6.03%
P/E	-86.6x	-2.84x	-2.09x	-1.02x	-1.58x	-2.98x	20.4x
PBR	1.17x	0.59x	0.28x	0.27x	0.17x	0.18x	0.17x
PEG	7.8x	-0x	0.1x	-0x	0x	0.1x	-0x
Capitalization / Revenue	1.33x	0.54x	0.3x	0.25x	0.16x	0.15x	0.15x
EV / Revenue	1.38x	0.73x	0.3x	0.2x	0.1x	0.15x	0.15x
EV / EBITDA	11.2x	7.89x	5.37x	2.53x	1.34x	1.64x	1.45x
EV / EBIT	28.5x	44x	-10.2x	-2.26x	-12.2x	69.6x	4.88x
EV / FCF	-11x	-5.75x	18.2x	3.35x	1.05x	3.84x	13.6x
FCF Yield	-9.09%	-17.4%	5.51%	29.8%	95.6%	26.1%	7.38%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-0.16	-2.02	-1.38	-2.23	-0.7966	-0.423	0.0618
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	976.6	1,013	911.9	848.2	760.5	781.6	804.9
EBITDA ¹	120	93.1	50.4	66.2	58.58	70.3	83.91
EBIT ¹	47.3	16.7	-26.4	-74.3	-6.433	1.652	25.02
Net income ¹	-15	-189.7	-130.6	-211.2	-75.7	-40.25	5.886
Net Debt ¹	46.3	191	-3.9	-48.4	-41.66	-5.063	1.872
Reference price ²	13.850	5.730	2.880	2.270	1.262	1.262	1.262
Nbr of stocks (in thousands)	94,010	94,913	95,263	95,214	95,188	-	-
Announcement Date	08/03/23	28/02/24	03/03/25	03/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.93x	12.83x	26.95x	0.56%	1,07900Cr
JOHNSON & JOHNSON	28.47x	6.51x	18.01x	2.02%	64TCr
ABBVIE INC.	33.14x	7.75x	15.92x	2.61%	47TCr
ROCHE HOLDING AG	20.04x	4.79x	11.87x	2.76%	35TCr
NOVARTIS AG	22.45x	5.8x	14.46x	2.76%	30TCr
ASTRAZENECA PLC	22.33x	4.59x	13.01x	1.91%	27TCr
NOVO NORDISK A/S	14.91x	5.52x	11.38x	3.36%	23TCr
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	21TCr
GILEAD SCIENCES, INC.	-47.83x	5.73x	31.65x	2.48%	16TCr
Average	17.21x	6.69x	17.22x	2.34%	41.22TCr
Weighted average by Cap.	25.10x	8.05x	18.96x	1.93%